No exits recorded yet.
0 funds tracked, 0 portfolio companies (0 active · 0 realized). Verified weekly from public filings and deal announcements.
Holland Capital is a 40 plus year Dutch mid-market private equity specialist with approximately €270 million of assets under management as of December 2024, headquartered in Amsterdam with a second office in Düsseldorf, Germany. The firm was founded in 1981 as one of the first independent Dutch private equity and participations firms and operates as a partner-owned independent firm with approximately 155 investments lifetime. The latest vehicle, Growth & Buy-Out Fund V, closed at its €225 million hard cap.
Holland Capital deploys capital through approximately five plus funds (through Growth & Buy-Out Fund V), targeting growth capital and buy-out investments in lower-mid-market companies riding multi-year structural growth trends, with active hands-on support. Sector focus follows a three-pillar thesis spanning healthcare services and medical devices and diagnostics and digital health, IT services and software and high-tech equipment, and agrifood-tech and energy transition. Geographic deployment is Benelux and Germany.
Recent realised exits include medical devices (2024), assistive health technology (2024) and two healthcare services exits (2025). Recent acquisitions include a healthcare services and childcare platform (2026), medical equipment (2026) and industrial automation software (2026). The platform continues active deployment of Fund V across the Benelux and German mid-market mandate. Detailed buyer names and multiple data available on Pro at €49/month.
Other private equity firms tracked on GP Intel.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in